AIM: To compare PD-L1 expression between metastatic uveal melanoma (MUM) and metastatic cutaneous melanoma (MCM). MATERIALS & METHODS: A total of 295 MCM and 78 MUM specimens were analyzed for tumor cell PD-L1 expression. Additionally, 91 MCM and 45 MUM specimens were analyzed for PD-1 expression on tumor-infiltrating lymphocytes. RESULTS: A total of 77/295 (26.1%) MCM specimens expressed PD-L1 as compared to 4/78 (5.1%) MUM specimens (p < 0.0001). PD-1 expression on tumor-infiltrating lymphocytes was greater in MCM (73.6%; 67/91) than in MUM (51.1%; 23/45), respectively (p = 0.009). CONCLUSION: Significant differences exist in PD-L1 expression between MCM and MUM. The lower PD-L1 expression in MUM may provide a rationale for failure of PD-1 inhibitor therapy and suggests that immune evasion in this disease may occur via alternative mechanisms.
AIM: To compare PD-L1 expression between metastatic uveal melanoma (MUM) and metastatic cutaneous melanoma (MCM). MATERIALS & METHODS: A total of 295 MCM and 78 MUM specimens were analyzed for tumor cell PD-L1 expression. Additionally, 91 MCM and 45 MUM specimens were analyzed for PD-1 expression on tumor-infiltrating lymphocytes. RESULTS: A total of 77/295 (26.1%) MCM specimens expressed PD-L1 as compared to 4/78 (5.1%) MUM specimens (p < 0.0001). PD-1 expression on tumor-infiltrating lymphocytes was greater in MCM (73.6%; 67/91) than in MUM (51.1%; 23/45), respectively (p = 0.009). CONCLUSION: Significant differences exist in PD-L1 expression between MCM and MUM. The lower PD-L1 expression in MUM may provide a rationale for failure of PD-1 inhibitor therapy and suggests that immune evasion in this disease may occur via alternative mechanisms.
Authors: Richard D Carvajal; Marcus O Butler; Alexander N Shoushtari; Jessica C Hassel; Alexandra Ikeguchi; Leonel Hernandez-Aya; Paul Nathan; Omid Hamid; Josep M Piulats; Matthew Rioth; Douglas B Johnson; Jason J Luke; Enrique Espinosa; Serge Leyvraz; Laura Collins; Howard M Goodall; Koustubh Ranade; Chris Holland; Shaad E Abdullah; Joseph J Sacco; Takami Sato Journal: Nat Med Date: 2022-10-13 Impact factor: 87.241
Authors: Sara Alavi; Ashleigh Jacqueline Stewart; Richard F Kefford; Su Yin Lim; Elena Shklovskaya; Helen Rizos Journal: Front Immunol Date: 2018-06-21 Impact factor: 7.561
Authors: Maria Sofia Basile; Emanuela Mazzon; Andrea Russo; Santa Mammana; Antonio Longo; Vincenza Bonfiglio; Matteo Fallico; Rosario Caltabiano; Paolo Fagone; Ferdinando Nicoletti; Teresio Avitabile; Michele Reibaldi Journal: PLoS One Date: 2019-01-17 Impact factor: 3.240
Authors: Anja Wessely; Theresa Steeb; Michael Erdmann; Lucie Heinzerling; Julio Vera; Max Schlaak; Carola Berking; Markus Vincent Heppt Journal: Int J Mol Sci Date: 2020-01-29 Impact factor: 5.923